Lactic acid bacteria and their effect on the immune system

Current Issues in Intestinal Microbiology

Volumn 2, Issue 1, 2001, Pages 27-42

  Perdigon G ^a   Fuller, R ^a   Raya, R ^a  

^a CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT; VACCINE;

ARTICLE; BIOLOGY; CANCER; CELL ACTIVATION; CONTROLLED STUDY; DIGESTIVE SYSTEM; DISEASE CARRIER; ECOSYSTEM; EPITHELIUM CELL; FOOD; HOST; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; INFECTION; INTESTINE; INTESTINE FLORA; LACTIC ACID BACTERIUM; MICROFLORA; MICROORGANISM; MUCOSAL IMMUNITY; NONHUMAN; PROTECTION; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; IMMUNE SYSTEM; IMMUNITY, MUCOSAL; INTESTINES; LACTOBACILLUS; MICE; PROBIOTICS;

EID: 0035050094     PISSN: 1466531X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (172)

1. Involvement of CD lymphocytes in the production of interferon induced by non-pathogenic bacteria
2. Lactic acid bacteria and the control of tumours in the lactic acid bacteria
3. Adjuvanticity of the cholera toxin A1-based gene fusion protein, CTA1-DD, is critically dependent on the ADP-ribosyltransferase and Ig-binding activity
4. Specific immunity induction at mucosal level by viable Lactobacillus casei. Perspective for oral vaccine development
5. Antitumour activity of Lactobacillus casei (LC9018) against experimental mouse bladder tumour (MBT-2)
6. Antitumour component(s) of yogurt: Fractionation
7. Ion exchange separation of the antitumor component(s) of yogurt dialyzate
8. Bifidobacteria and probiotic action
9. Bronchial mucosal lymphoid tissue
10. Adjuvanticity of Lactobacilli. I. Differential effects of viable and killed bacteria
11. Expression of a nonpolymorphic MHC class I-like molecule, CD1 intestinal epithelial cells
12. Antitumor glycopeptides from Lactobacillus bulgaricus cell wall
13. Early development of Ig-secreting cells in young of germ-free BALB/c mice fed a chemically defined ultrafiltered diet
14. Overview of the mucosal immune system
15. The enterocyte and immunoglobulin transport
16. Halstensen, Mette Hvatum Dag Kvale, Helge Scott
17. Structure, distribution and origin of M cells in Peyer's patches of mouse ileum
18. Are Peyer's patch germinal Centre reactions different from those occurring in other lymphoid tissues?
19. Systemic tolerance and secretion immunity after oral immunization
20. Distribution of pathogen inhibition in the Lactobacillus isolates of a commercial probiotic consortium
21. Oral immunization of humans with dehydrated liposomes to an oral liposomes containing Streptococcus mutans carbohydrate vaccine in humans
22. Differential expression of lectin-binding sites defines mouse intestinal M-cells
23. Induction and assessment of immunity at enteromucosal surfaces in humans: Implications for vaccine development
24. The adjuvant effect of yogurt on production of gamma-interferon by ConA-stimulated human peripheral blood lymphocytes
25. Stimulation of host resistance by a diet supplemented with yogurt
26. The role of probiotics in modulation of the immune system in man and in animals
27. Triggered human T cells release tumour necrosis factor-alpha and interferon-gamma which kill human colonic epithelial cells
28. Oral tolerance: A commentary
29. Lectins are sensitive tools for defining the differentiation programs of epithelial cell lineages in the developing and adult mouse gastrointestinal tract
30. Boosted systemic immune and local responsiveness after intestinal inflammation in orally sensitized guinea pigs
31. Therapeutic role of dietary lactobacilli and lactobacilli fermented dairy products
32. Control of diarrhea by lactobacilli
33. Changes in the rate of crypt epithelial cell proliferation and mucosal morphology induced by a T-cell-mediated response in human small intestine
34. Antitumour properties of lactobacilli and dairy products fermented by lactobacilli
35. Effect of feeding and intraperitoneal implantation of yogurt culture cells on Ehrlich ascites tumour
36. Probiotics in man and animals
37. Health and nutritional benefits from lactic acid bacteria
38. Acidophilus milk: A review of potential health benefits to consumer
39. Antagonistic action of Lactobacillus acidophilus toward intestinal and foodborne pathogens in associative cultures
40. Effect of Lactobacillus acidophilus dietary supplements on 1,2-dimethylhydrazine dihydrochloride induced intestinal cancer in rats
41. Adhesion molecules and the modulation of mucosal inflammation
42. Cytotoxic factor production by Kupffer cells elicited with Lactobacillus casei and Corynebacterium parvum
43. Amelioration of the adverse effects of a gastrointestinal challenge with Salmonella enteridis on weaning rats by a yogurt diet
44. Efficient secretion of the model antigen M6-gp41E in Lactobacillus plantarum NCIMB 8826
45. Isotypes and specificities of immunoglobulins produced by germ-free chemically defined ultra-filtered antigen free diet
46. Antimutagenicity of milk cultured with lactic acid bacteria against N-methyl-N-nitrosoguanidine
47. The role of lactic acid bacteria as a scavenger of N-nitroso compounds in the intestinal tract
48. Antimutagenic and antitumour activities of lactic acid bacteria
49. A human Lactobacillus strain (Lactobacillus GG) promotes recovery from acute diarrhea in children
50. Potentiation of large intestinal tumorigencity of cycasin derivative by high fat diet and Lactobacillus in germ free mice
51. Mantenance of normal intestinal mucosa: Function, structural and adaptation
52. Adjuvants and delivery systems for viral vaccines- Mechanisms and potencial
53. Safety and immunogenicity of an oral recombinant cholera B subunit wholw cells vaccine in swedish volunteers
54. Administration of different Lactobacillus strains in fermented oatmeal soup. In vivo colonization of human intestinal mucosa and effect on the indigenous flora
55. Mucosal Immunology: New frontiers
56. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain
57. Effects of oral administration of Lactobacillus casei on antitumour responses induced by turmor resection in mice
58. Antitumor activity of Lactobacillus casei in mice
59. Macrophage activation by Lactobacillus casei in mice
60. Augmentation of mouse natural killer cell activity by Lactobacillus casei and its surface antigens
61. Induction of tumoricidal peritoneal exudates cells by administration of Lactobacillus casei
62. Liposomes and ISCOMs as vaccine formulation
63. Defence mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin proteases
64. Interferon induction in murine peritoneal macrophage by stimulation with Lactobacillus acidophilus
65. Expression of mRNA encoding IFN α in macrophages stimulated with Lactobacillus gasseri
66. Lack of oral tolerance in C3H/Hej mice
67. Genetics of intestinal lactobacilli
68. Controlled gene expression systems for lactic acid bacteria: Transferable nisin-inducible expression cassettes in Lactococcus, Leuconostoc, and Lactobacillus ssp
69. Antitumour and immunological adjuvant effect of Bifidobacterium infants in mice
70. Antitumour effect of Bifidobacterium infants in mice
71. Inducible gene expression and environmentally regulated genes in lactic acid bacteria
72. Tumour necrosis factor-alpha upregulates expression of secretory component, the epithelial receptor for polymeric Ig
73. New insights into epithelial cell function in mucosal immunity: Neutralization of intracellular pathogens and excretion of antigens by IgA
74. Effects of non-steroidal anti-inflammatory drugs and misoprostol on gastric and duodenal epithelial proliferation in patients with arthritis
75. Lactobacilli and the normal human anaerobic microflora
76. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk
77. Immunoadjuvants and analogs of immunomodulatory bacterial structures
78. Antitumor activity of Lactobacillus casei on Lewis Lung carcinoma and line-10 hepatoma in syngeneic mice and guinea pig
79. Immunologic supression after oral administration of antigen. I. Specific supressor cells formed in rat Peyer's patches after oral administration of sheep erythrocytes and their systemic migration
80. Expression of class II molecules on intestinal epithelial cells in humans. Differences between normal and inflammatory bowel disease
81. Intracellular neutralization of influenza virus by IgA anti-HA monoclonal antibodies
82. Intracellular neutralization of virus by immunoglobulin A antibodies
83. Mucosal immunity to vaccines: Current concepts for Vaccine development and immune response analysis
84. Lactic acid bacteria as live vaccines
85. Common mucosal immune system and strategies for the development of vaccines effective at the mucosal surfaces
86. Prospects for human mucosal vaccines
87. Intestinal IgA system
88. Targeted Mucosal Immunizations: Antigen delivery systems and compatmentalization of the common mucosal immune system
89. Biodegradable microspheres for the delivery of oral vaccines
90. Antigen delivery systems: New approaches to mucosal immunization
91. Lypopolysacharide (LPS) regulation of the immune response. LPS influence on oral tolerance induction
92. The IgA response: Inductive aspects, regulatory cells and effector functions
93. Two types of mouse helper T cell clone. Implications for immune regulation
94. The regulation of immune responses to dietary protein antigens
95. Inhibitory effects of transforming growth factor β 1 on mitogenic response, transforming growth factor alpha and cmyc in quiescent, web differentiated colon carcinoma cells
96. Antimutagenicity of fermented milk
97. M cells as a Pathway for antigen uptake and Processing
98. Influence of intestinal bacterial flora on cytokine (IL-1, IL-6 and TNF-alpha) production by mouse peritoneal macrophages
99. The effect of antimicrobial agents of the ecology of the human intestinal microflora
100. Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C
101. Probiotics and the immune state
102. Systemic and local augmentation of the immune response in mice by feeding with milk fermented with Lactobacillus acidophilus and/or Lactobacillus casei
103. Oral immunoadjuvant activity of L. casei influence of the dose administered on the secretory immune response and protective capacity in intestinal infections
104. Comparative effect of the adjuvant capacity of L. casei and LPS on the intestinal secretory antibody response and resistance to Salmonella infection in mice
105. Influence of the use of Lactobacillus casei as an oral adjuvant on the levels of secretory immunoglobulin A during an infection with Salmonella typhimurium
106. Influence of the oral administration of lactic acid bacteria on IgA producing cells associated to bronchus
107. Effect of lactic acid bacteria orally administered and of yoghurt on the immune system
108. The oral administration of lactic acid bacteria increases the mucosal intestinal immunity in response to enteropathogens
109. Lactobacilli administered orally induce release of enzymes from peritoneal macrophages in mice
110. Immune system stimulation by probiotics
111. Antitumor activity of orally administered L. casei significance of its dose in the inhibition of a fibrosarcoma in mice
112. Cytolytic effect of the serum of mice fed with Lactobacillus casei on tumour cell
113. Immunomodulation effect of lactic acid bacteria on mucosal and tumour immunity
114. Intestinal pathway of internalisation of lactic acid bacteria and gut mucosal immunostimulation
115. Prevention of gastrointestinal infection using immunobiological methods with milk fermented with Lactobacillus casei and Lactobacillus acidophilus
116. Effect of perorally administered lactobacilli on macrophage activation in mice
117. Effect of a mixture of Lactobacillus casei and Lactobacillus acidophilus administered orally on the immune system in mice
118. Enhancement of immune response in mice fed with Streptococcus thermophilus and Lactobacillus acidophilus
119. Systemic augmentation of the immune response in mice by feeding fermented milks with Lactobacillus casei and Lactobacillus acidophilus
120. Modulation of the immune response of the immunosuppressed host by probiotics
121. Effect of the oral administration of yogurt on the small and large intestine associated lymphoid cells in mice
122. Antitumor activity of yogurt. Study of the possible involved immune mechanisms
123. Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria
124. Immunomodulation of the gastrointestinal epithelium
125. Induction of human cytokines by bacteria used in dairy foods
126. Synergistic effect of IL-4 and IFN-gamma on the expression of polymeric lg receptor (secretory component) and IgA binding by human epithelial cells
127. Migration of lymphocytes in the mucosal immune system
128. Cell wall anchoring of the Streptococcus pyogenes M6 protein in various lactic acid bacteria
129. Stimulating effect of DEODAN (an oral preparation from Lactobacillus bulgaricus 'LB51″) on monocytes/macrophages and host resistance to experimental infections
130. The potential of Lactobacillus as a carrier for oral immunization: Development and preliminary characterization of vector systems for targeted delivery of antigens
131. Immunomodulating effects of antibiotics on Intestinal microflora
132. Antitumour activity of yogurt components
133. Inhibitory effect of yogurt on Ehrilich ascites tumour-cell proliferation
134. Human intestinal epithelial cells express functional cytokine receptors sharing the yc chain of the interleukin-2 receptor
135. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis
136. Enhanced humoral antibody production and delayed type hypersensitivity response in mice by Lactobacillus casei
137. Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures
138. Lactic acid bacteria in the gut in normal and disordered states
139. Probiotics and stabilization of the gut mucosal barrier
140. Clinical uses of probiotics for stabilising the gut mucosal barrier: Successful strains and future challenges
141. High level heterologous protein production in Lactococcus and Lactobacillus using a new secretion system based on the Lactobacillus brevis S-layer signals
142. Clinical efficacy of a human Lactobacillus strain as a probiotic
143. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria
144. A Common Mucosal Immune System Revisited
145. A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice
146. Antitumor activity of fermented colostrum and milk
147. Pathogenic lactobacilli
148. Induction of human cytokines by bacteria used in dairy foods
149. Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine
150. Functional display of a heterologous protein on the surface of Lactococcus lactis by means of the cell wall anchor of Staphylococcus aureus protein A
151. Oral tolerance
152. Initial safety and immunogenicity studies of an oral recombinat adenohepatitis B vaccine
153. Tumour-suppressive effect of a cell wall preparation, WPG, from Bifidobacterium infantis in germfree and flora-bearing mice
154. Effect of Streptococcus faecium C-68 in control of Escherichia coli induced diarrhea in gnotobiotic pigs
155. Cytotoxic activity of peritoneal macrophages of mice fed with yogurt in an intestinal tumour process
156. Gut mucosal immunostimulation by lactic acid bacteria
157. The enterocyte and antigen transport
158. Oral tolerance: Immune mechanisms and treatment of autoimmune Diseases
159. Organ and isotype distribution of plasma cells producing specific antibody after oral immunization: Evidence for a generalized secretory immune system
160. Progress in the development of mucosal vaccines based on Lactococcus lactis
161. Lactic acid bacteria as vaccine delivery vehicles
162. Lactococcus lactis: High level expression of tetanus toxin in fragment C and protection against lethal challenge
163. Antigen presenting cells of the small Intestinal lamina propria
164. The germfree animal fed chemically defined diet. A unique tool
165. Growth factors in gastrointestinal mucosal inflammation
166. Passive protection against rotavirus-induced diarrhea of mouse pups born to and nursed by dams fed Bifidobacterium breve YIT 4064
167. Host mediated antitumor activity of Lactobacillus casei in mice
168. Comparison of antitumor activity of Lactobacillus casei with other bacterial immunopotentiators